Weboxfam america in support of petitioners _____ diana kearney legal and shareholder advocacy advisor oxfam america 1101 17th street, nw suite 1300 washington dc 20036 … WebDiana Kearney Oxfam America COVID-19 Vaccine Technology Transfer Business Case: Backlash from refusal to share information needed to manufacture vaccines in low- and middle-income countries could tarnish pharmaceutical companies’ reputations, threaten their social license to operate, and undermine relations with the U.S. government. Companies:
OxFam Training - Harvard Law School Harvard Law School
WebClinic, Harvard, Diana Kearney, Oxfam America Closing Remarks: Irit Tamir Speaker Bios Amol Mehra Amol Mehra is the Director of Industry Transformation at the Laudes Foundation where he oversees programmes relating to transformation of the fashion and built environment sectors to address the dual crises of inequality and climate change. WebMar 4, 2024 · Diana Kearney, senior legal adviser at Oxfam America, said that "thousands of families at the border can breathe a momentary sigh of relief today" and described the … shann brewington
Transforming Adversary to Ally: Mobilizing Corporate Power for …
Weboxfam america in support of petitioners _____ diana kearney legal and shareholder advocacy advisor oxfam america 1101 17th street, nw suite 1300 washington dc 20036-4710 diana. kearney@ oxfam. org emily johnson henn counsel of record covington & burling llp 3000 el camino real 5 palo alto square, 10th floor palo alto, ca 94306-2112 … WebDec 21, 2024 · Diana Kearney, senior legal advisor for legal and shareholder advocacy at Oxfam America, said Moderna must be held accountable. WebMar 15, 2024 · March 15, 2024 Diana Kearney. Oxfam and co-filers have filed shareholder proposals at Moderna and Pfizer asking the companies to study how they might transfer Covid-19 vaccine technology and know-how to manufacturers in low- and middle-income countries. The companies’ refusal to transfer mRNA technology is prolonging the Covid … polyp in hepatic flexure